- Kristi Powers
Choose the health content that’s right for you, and get it delivered right in your inbox.

A new genetic test for patients with colorectal cancer, being studied at AdventHealth, can detect if a patient has cancer from a simple blood draw. The groundbreaking test could allow patients to avoid chemotherapy after having surgery to remove a tumor. The test searches for circulating tumor DNA (ctDNA), which is a sequencing technology that can detect very small amounts of tumor DNA in the body’s circulatory system.
“What we knew is that a lot of those patients were cured with surgery alone. We just didn’t have a way to know which ones had microscopic cancer left in the blood, who needed chemo and who did not,” said Dr. Mohamedtaki Tejani, medical oncologist and director of the Gastrointestinal Oncology program at the AdventHealth Cancer Institute and the AdventHealth Research Institute, told the Orlando Sentinel.
Colorectal cancer is the fourth most common cancer diagnosed in the U.S. and the second leading cause of cancer-related deaths. Dr. Tejani is leading the AdventHealth site with two National Cancer Institute clinical trials that aim to harness this sequencing technology to improve patient care. The trial related to Stage 3 colon cancer and the BESPOKE study are currently enrolling participants through a referral process with the AdventHealth Gastrointestinal Oncology Program. Click the link for each study for more information on how to enroll.
In the future, Dr. Tejani hopes this genetic test, which has to be ordered by a physician, can also be used to prescreen for very early-stage colon cancer, and also more effectively treat other cancers, such as gynecologic or pancreatic cancers.
Read the full Orlando Sentinel story here.
Recent News
AdventHealth Tampa is expanding to meet the growing health care needs of the community with a new five-story, 100,000-square-foot medical office building and a seven-story parking garage that will add...
We are proud to celebrate 29 outstanding AdventHealth Medical Group Rocky Mountain Region physicians who have been recognized with 5280 Magazine’s 2025 Top Doctor award.
AdventHealth facilities in Hillsborough, Pasco & Marion counties celebrate a major leap in clinical excellence with top designations from the global leader in hospital rankings.
These honors reflect the organization’s continued commitment to providing exceptional care and expanding access to advanced services throughout the western suburbs.
When a devastating tornado unraveled her world, Megan Vanhook found herself facing not only the loss of her home, but the emotional weight that followed.
More than 20 AdventHealth hospitals across the country earned recognition in the 2025–2026 U.S. News & World Report Best Hospitals rankings.
For the first time, four hospitals from AdventHealth’s East Florida Division have been ranked among U.S. News & World Report’s Best Hospitals — signaling rising clinical performance and growing...
AdventHealth is excited to welcome Bing-Xue “Jasmine” Lin, MD, FACOG, to its team at AdventHealth Medical Group Obstetrics and Gynecology at Hendersonville*, a new location dedicated to providing...
The hospital was also recognized as a national leader in 11 clinical specialties, and as the Orlando area’s best hospital for the 15th year in a row.
AdventHealth opened the expanded Wellsville Health Park to boost rural care access, featuring more services and space for the local community.
AdventHealth Hendersonville is celebrating its Breast Center teams across Western North Carolina for earning the renewal of the prestigious national accreditation for exceptional breast cancer care.
At the annual Becker's Hospital Review conference, chief nursing officer Cathy Stankiewicz discusses how AdventHealth is strengthening its RN workforce.